Ready to bring the next big medical breakthrough to market?

The m1 Mission
M1 is a medical technology accelerator that supports early-stage medical device founders looking to rapidly progress toward commercialization.
We bring together a wide network of founders, advisors, service providers, and subject matter experts to guide cohort teams during and beyond the program. Cohort teams receive an equity investment and participate in a three-month, hands-on, practical workshop curriculum designed to drive them through company and product development in weeks instead of years.
The M1 program is a highly technical accelerator designed to aid founders in rapidly advancing toward commercialization and prepare them for critical early investment stages.
M1 starts by making an upfront equity investment in each cohort company. Then, each cohort participates in a practical, hands-on 14-week workshop curriculum led by vetted subject matter experts, covering a variety of topics including company formation and management, intellectual property, design and quality controls, preclinical and clinical testing, and regulatory approval.
The M1 team and our partners also provide ongoing mentoring and coaching of each team accepted into the program.
Finally, M1 offers in-person network and presentation opportunities, including our program kickoff, investor dinners, and preliminary and final pitch events.
How we're different
M1 offers a unique approach to the accelerator framework.
Our program focuses on providing a personal, founder-centered experience by accepting a limited number of companies into each cohort and providing ongoing tailored mentoring and coaching for each company. Additionally, our educational curriculum leans heavily on practical, interactive workshop sessions where cohort companies quickly push through milestones as they continually develop their business. Finally, M1 provides each team with specific, tailored connections vetted by our team through professional partnerships.
Want to stay up to date on M1?
Sign up here for recent updates!
The M1 team has a breadth of experience across medical and biotechnology development from the discovery phase to product launch and beyond. Together with our network of expert partners, our team educates, coaches, and supports founders in driving their devices toward commercialization.
Kevin is an attorney and is certified in regulatory affairs. He has worked with hundreds of pharmaceutical, biotech, and life science companies.
Kevin Coker, JD, MPH, MS
CEO & Co-Founder
Ms. Schmitt has also served in additional regulatory affairs and clinical research roles in which she contributed to multiple regulatory submissions and clinical affairs projects across a wide range of indications.
Isabella Schmitt, RAC
Director of Regulatory Affairs
He is a Distinguished American Award recipient from the Horatio Alger Association.
Larry Lawson
Founder & Executive Chairman
While in graduate school, Sean developed a passion for personal and professional development, particularly leadership development.
Sean Bittner, PhD
Director of Programs, New Ventures
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.